Literature DB >> 8997852

Asymptomatic rotavirus infection within Benin City urban community, Nigeria.

A I Omoigberale1, J O Ojukwu, P O Abiodun.   

Abstract

This study was carried out in Benin City urban community, Nigeria as a follow-up of an earlier study carried out on patients admitted to the University of Benin Teaching Hospital. The aim of the present study was to determine the prevalence of asymptomatic rotavirus infection amongst urban children and adults. Eight hundred and twenty one subjects from 200 homes were screened for rotavirus infection between August and December 1990. The 821 stool samples collected from the subjects (541 children and 280 adults) were subjected to studies at the University of Benin Teaching Hospital. Detection of rotavirus antigen was done by the ELISA method. The overall prevalence of asymptomatic rotavirus infection in this study was 30.8%. The results reflect a high source of reservoir for spread of rotavirus infection within the community.

Entities:  

Mesh:

Year:  1996        PMID: 8997852

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  3 in total

1.  Nonsecretor Histo-blood Group Antigen Phenotype Is Associated With Reduced Risk of Clinical Rotavirus Vaccine Failure in Malawian Infants.

Authors:  Louisa Pollock; Aisleen Bennett; Khuzwayo C Jere; Queen Dube; Jonathan Mandolo; Naor Bar-Zeev; Robert S Heyderman; Nigel A Cunliffe; Miren Iturriza-Gomara
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

2.  Molecular epidemiology of group A human rotaviruses in North West region, Cameroon.

Authors:  Florence Azie Mbuh; George Enyimah Armah; Sunday Aremu Omilabu; Aliyu Ahmadu Ahmad; Jarlath Udoudo Umoh
Journal:  Pan Afr Med J       Date:  2012-08-15

3.  Symptomatic and subclinical infection with rotavirus P[8]G9, rural Ecuador.

Authors:  Pablo Endara; Gabriel Trueba; Owen D Solberg; Sarah J Bates; Karina Ponce; William Cevallos; Jelle Matthijnssens; Joseph N S Eisenberg
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.